June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Effectiveness of intraoperative Optical Coherence Tomography (iOCT) on vitrectomy for proliferative diabetic retinopathy
Author Affiliations & Notes
  • Koichi Nishitsuka
    Ophthalmology/Vis Sci, Yamagata University Sch of Med, Yamagata-shi, Yamagata, Japan
  • Madonna Nakamura
    Ophthalmology/Vis Sci, Yamagata University Sch of Med, Yamagata-shi, Yamagata, Japan
  • Katsuhiro Nishi
    Ophthalmology/Vis Sci, Yamagata University Sch of Med, Yamagata-shi, Yamagata, Japan
  • Hiroyuki Namba
    Ophthalmology/Vis Sci, Yamagata University Sch of Med, Yamagata-shi, Yamagata, Japan
  • Yutaka Kaneko
    Ophthalmology/Vis Sci, Yamagata University Sch of Med, Yamagata-shi, Yamagata, Japan
  • Hidetoshi Yamashita
    Ophthalmology/Vis Sci, Yamagata University Sch of Med, Yamagata-shi, Yamagata, Japan
  • Footnotes
    Commercial Relationships   Koichi Nishitsuka, None; Madonna Nakamura, None; Katsuhiro Nishi, None; Hiroyuki Namba, None; Yutaka Kaneko, None; Hidetoshi Yamashita, Alcon Japan Ltd. (F), AMO Japan (F), Atsuzawa Prosthesis Co., Ltd. (F), B.L.J Company, Ltd. (F), Bayer Yakuhin, Ltd. (F), Eisai Co., Ltd. (F), NOVARTIS Pharma Japan (F), SENJU PHARMACEUTICAL Co., Ltd. (F), Taisho Pharma Japan (F), Trust Medical Co., Ltd. (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3312. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Koichi Nishitsuka, Madonna Nakamura, Katsuhiro Nishi, Hiroyuki Namba, Yutaka Kaneko, Hidetoshi Yamashita; Effectiveness of intraoperative Optical Coherence Tomography (iOCT) on vitrectomy for proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3312.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To verify the effect of intraoperative OCT (iOCT) on vitrectomy for the treatment of proliferative diabetic retinopathy (PDR).

Methods : This retrospective study included 98 eyes of patients with PDR (mean age, 52.5 ± 11.7 years) who were treated with vitrectomy using iOCT (iOCT group) and 80 eyes from patients with PDR (mean age, 53.1 ± 10.9 years) who were treated without iOCT (non-iOCT group). The two groups were compared for intraoperative complications, reoperation ratio, postoperative complications, operation time, and postoperative visual acuity.

Results : The incidences of intraoperative complications were 13.8% and 17.3% (P = 0.542) in the iOCT and non-iOCT groups, respectively, and the reoperation rates were 10.0% and 5.1% (P = 0.254), respectively. The incidence of postoperative complication was [A1] 22.5% and 24.5% (P = 0.860), respectively, and there was no significant difference between the two groups. The operation time was significantly higher in the non-iOCT group (91.3 ± 31.2 min) than in the iOCT group (72.9 ± 23.9 min). Six months after surgery, the postoperative visual acuity was not significantly different between the two groups (P = 0.508).

Conclusions : The use of iOCT reduced the operation time without affecting the incidence of intraoperative and postoperative complications, reoperation ratio, and postoperative visual acuity in patients who underwent vitreous surgery for PDR.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×